Changes in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPD
暂无分享,去创建一个
J. Wedzicha | G. Donaldson | Timothy D McHugh | A. Mackay | A. Patel | D. Garcha | S. Thurston | J. Goldring
[1] F. Martinez,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.
[2] J. Søndergaard,et al. Divergent Pro-Inflammatory Profile of Human Dendritic Cells in Response to Commensal and Pathogenic Bacteria Associated with the Airway Microbiota , 2012, PloS one.
[3] T. Seemungal,et al. Reported pneumonia in patients with COPD: findings from the INSPIRE study. , 2011, Chest.
[4] J. Curtis,et al. Analysis of the Lung Microbiome in the “Healthy” Smoker and in COPD , 2011, PloS one.
[5] V. J. Cid,et al. Nontypable Haemophilus influenzae: an intracellular phase within epithelial cells might contribute to persistence. , 2011, Microbiology.
[6] D. Knol,et al. Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD. , 2010, Chest.
[7] Eoin L. Brodie,et al. A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations. , 2010, Omics : a journal of integrative biology.
[8] Lior Pachter,et al. Disordered Microbial Communities in Asthmatic Airways , 2010, PloS one.
[9] J. Wedzicha,et al. Defective macrophage phagocytosis of bacteria in COPD , 2009, European Respiratory Journal.
[10] J. Blomberg,et al. Toward a quantitative DNA-based definition of pneumococcal pneumonia: a comparison of Streptococcus pneumoniae target genes, with special reference to the Spn9802 fragment. , 2008, Diagnostic microbiology and infectious disease.
[11] T. Seemungal,et al. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. , 2008, American journal of respiratory and critical care medicine.
[12] T. Seemungal,et al. COPD exacerbations: defining their cause and prevention , 2007, The Lancet.
[13] P. Van der valk,et al. The role of atypical respiratory pathogens in exacerbations of chronic obstructive pulmonary disease , 2007, European Respiratory Journal.
[14] W. Coulter,et al. Evaluation of real-time PCR for the detection and quantification of bacteria in chronic obstructive pulmonary disease. , 2007, FEMS immunology and medical microbiology.
[15] Bartolome Celli,et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. , 2007, The New England journal of medicine.
[16] C. Mathers,et al. Projections of Global Mortality and Burden of Disease from 2002 to 2030 , 2006, PLoS medicine.
[17] John R Hurst,et al. Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. , 2006, American journal of respiratory and critical care medicine.
[18] S. Johnston,et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. , 2006, American journal of respiratory and critical care medicine.
[19] Tania Nolan,et al. SPUD: a quantitative PCR assay for the detection of inhibitors in nucleic acid preparations. , 2006, Analytical biochemistry.
[20] J. Wedzicha,et al. Effect of Interactions Between Lower Airway Bacterial and Rhinoviral Infection in Exacerbations of COPD , 2006, Chest.
[21] A. Torres,et al. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. , 2005, Archives of internal medicine.
[22] T. Murphy,et al. Persistent colonization by Haemophilus influenzae in chronic obstructive pulmonary disease. , 2004, American journal of respiratory and critical care medicine.
[23] R. Stockley,et al. Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis , 2003, Thorax.
[24] J. Wedzicha,et al. Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.
[25] D. Nadal,et al. Quantitative Detection of Moraxella catarrhalis in Nasopharyngeal Secretions by Real-Time PCR , 2003, Journal of Clinical Microbiology.
[26] M. Altwegg,et al. Development of a multiplex real-time quantitative PCR assay to detect Chlamydia pneumoniae, Legionella pneumophila and Mycoplasma pneumoniae in respiratory tract secretions. , 2003, Diagnostic microbiology and infectious disease.
[27] T. Seemungal,et al. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations , 2002, Thorax.
[28] B. Grant,et al. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. , 2002, The New England journal of medicine.
[29] C. Domingo,et al. Serological evidence of Legionella species infection in acute exacerbation of COPD , 2002, European Respiratory Journal.
[30] I. Boldur,et al. Chlamydia pneumoniae Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Analysis of 250 Hospitalizations , 2001, European Journal of Clinical Microbiology and Infectious Diseases.
[31] R. Stockley,et al. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. , 2000, The American journal of medicine.
[32] M. Miravitlles,et al. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD. , 1999, Chest.
[33] T. Seemungal,et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.
[34] J. Ruiz,et al. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. , 1995, American journal of respiratory and critical care medicine.
[35] T. Murphy,et al. Bacterial infection in chronic obstructive pulmonary disease. , 1992, The American review of respiratory disease.